NCT07040085 - Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke | Biotech Hunter

Enrollment

892

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Stroke

Interventions

DRUG

Y-6

each tablet of Y-6 contained 6 mg of dexborneol and 25 mg of cilostazol; Both groups took one tablet q12h for 28 days.

DRUG

Y-6 placebo

each tablet of Y-6 placebo contained 0.06 mg of dexborneol and 0 mg of cilostazol. Both groups took one tablet q12h for 28 days.